Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus

Table 1 Liver dysfunction of 66 patients after anti-TB treatment (mean±SD).

	HPBE (S) (n = 53)	HLAMKO (n = 13)	Total (n = 66)
Age (yr)	43±10	46±13	44±12
Sex (M/F)	38/15	9/4	47/19
T-Bil (mmol/L)	26 (6-202)	22 (8-112)	25 (6-202)
Albumin (g/L)	41±5.2	44±6.4	41±6.1
Globulin (g/L)	30±4.8	31±6.2	30±5.7
AST (IU/L)	2271±37	2134±42	2204±41
ALT (IU/L)	2538±64	2688±79	2622±75

Table 2 Effect of HBV on liver function after anti-TB treatment (%).

Group	HPBE(S) (%)	HLAMKO (%)
HBV carriers	19/24 (79.2)b	7/23 (30)b
HBeAg+	8/10 (80)d	3/10 (30)
HBeAg-	11/14 (79)	4/13 (31)
Noncarriers	34/91 (37)	6/79 (8)

^bP<0.01 vs noncarriers,

^dP<0.01 vs HPBE(S).